References
- Angst J, Gamma A. A new bipolar spectrum concept: a brief review. Bipolar Dis.4(Suppl. 1), 11–14 (2002).
- Judd LL, Akiskal JS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Dis.73, 123–131 (2003).
- Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: ‘dark’ and ‘sunny’ expressions of soft bipolarity. J. Affect. Dis.73, 49–57 (2003).
- Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Dis.2, 3–7 (2000).
- Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psych.59, 530–537 (2002).
- Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psych.60, 261–269 (2003).
- Ghaemi SN, Hsu KJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Dis.5, 421–433 (2003).
- Moller JH, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur. Arch. Psych. Clin. Neurosci.250, 57–68 (2000).
- Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am. J. Psych.161, 1537–1547 (2004).
- Altshuler L, Kiriakos L, Calcagno J et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J. Clin. Psych.62, 612–616 (2001).
- Altshuler L, Suppes T, Black D et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am. J. Psych.160, 1252–1262 (2002).
- Post RM, Leverich GS, Nolen WA et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Dis.5, 396–406 (2003).
- Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine–fluoxetine combination in the treatment of bipolar depression. Arch. Gen. Psych.60, 1079–1088 (2003).
- Calabrese J, Macfadden W, McCoy R, Minkwitz M, Wilson E, Mullen J. Double-blind, placebo-controlled study of quetiapine in bipolar depression. Presented at Annual Meeting of the American Psychiatric Association, NY, USA (2004).
- Tohen M, Bowden C, Calabrese J. Olanzapine’s efficacy for relapse prevention in bipolar disorder: a randomized double-blind control 12 month clinical trial. Presented at the Fifth International Conference on Bipolar Disorder, PA, USA (2001).
- Tohen M, Marneros A, Bowden C. Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized double-blind control 12 month clinical trial. Presented at 43rd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, FL, USA (2003).
- Tohen M, Ketter TA, Zarate CA et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47 week study. Am. J. Psychiatry160, 1263–1271 (2003).
- Van Gorp WG, Altshuler LL, Theverge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence: a preliminary study. Arch. Gen. Psych.55, 41–46 (1998).
- Gitlin MJ, Hammen C. Syndromal and psychosocial outcome in bipolar disorder: a complex and circular relationship. In: Bipolar Disorders: Clinical Course and Outcome. Goldberg JF, Harrow M (Eds). American Psychiatric Press, Inc., Washington DC, USA ,39–55 (1999).